Cargando…
Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
Autores principales: | Zhou, Zeqi, Wang, Xiangbin, Fu, Yankai, Zhang, Xiqing, Liu, Changxiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668178/ https://www.ncbi.nlm.nih.gov/pubmed/33224722 http://dx.doi.org/10.1016/j.apsb.2020.10.025 |
Ejemplares similares
-
Letter to the Editor: Neurohospitalist and COVID-19
por: Duong, Lisa, et al.
Publicado: (2020) -
Letter to the Editor Regarding “Letter to the Editor: Spinal and Neurosurgical Publications During the COVID-19 Era”
por: Akhaddar, Ali, et al.
Publicado: (2020) -
Letter to the editor: The effect of hydroxychloroquine on COVID-19
por: Demir, Canan, et al.
Publicado: (2022) -
Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment
por: Jin, Tianru, et al.
Publicado: (2020) -
Letter to the Editor
por: Adams, Carson, et al.
Publicado: (2013)